Stock Market Today: Nvidia Enters Correction Territory
The chipmaker has declined nearly 13% since hitting an all-time closing high earlier this month.
Stocks were mixed to start the new week. A big rally in energy stocks kept the Dow Jones Industrial Average above water, though the S&P 500 and Nasdaq Composite weren't so resilient.
Indeed, the Dow rose 0.7% to 39,411 on strength in Chevron (CVX), marking the 30-stock average's fifth-straight gain. The oil stock added 2.6% as U.S. crude futures climbed 1.1% to $81.63 per barrel.
However, the S&P 500 (-0.3% at 5,447) and the Nasdaq (-1.1% at 17,496) each finished lower as mega-cap chipmaker Nvidia (NVDA) continued to slide. NVDA ended today down 6.7% and is now in correction territory after falling nearly 13% from its June 18 all-time closing high. This late-June slide has chopped $432 billion from Nvidia's market value, which is more than the entire market cap of credit card giant Mastercard (MA, +0.5%).
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Even with these recent losses, NVDA has still more than doubled on a year-to-date basis and BofA Securities analyst Vivek Arya thinks any volatility will be short-lived.
For one, we are only in year two of what could be a three-to-five-year deployment cycle for generative artificial intelligence (GenAI) hardware, the analyst says. Additionally, Arya expects strong demand for Nvidia's Blackwell AI platform when it is launched later this year.
And "unlike the 'dot-com boom' that was funded by risky debt-taking, GenAI deployment is a mission-critical race between some of the best-funded (cloud) customers," Arya says, adding that NVDA remains a "top pick" at BofA.
Target gains on new Shopify deal
In other single-stock news, Target (TGT, +2.4%) said it teamed up with Shopify (SHOP, -1.1%) to boost the discount retailer's e-commerce sales.
While terms of the deal were not disclosed, the partnership will allow companies working with Shopify to sell items on Target Plus, its third-party marketplace. The retailer will also put certain popular items in its brick-and-mortar stores, one executive told CNBC.
Affirm could double on Apple partnership, analyst says
Elsewhere, Affirm (AFRM) shares jumped 12.8% after Mizuho Securities analyst Dan Dolev said the buy-now-pay-later firm's (BNPL) new partnership with Apple (AAPL, +0.3%) could drive major upside both on and off the price charts. The deal, announced at Apple's WorldWide Developer Conference (WWDC) earlier this month, will allow Apple Pay users to access installment loans through Affirm.
"We estimate that the new Apple Pay + Affirm partnership could drive roughly $12 billion potential incremental BNPL opportunity to Affirm, or 35% incremental growth vs fiscal 2025 consensus volume estimates," Dolev wrote in a note to clients. The analyst has a Buy rating on Affirm and a Street-high $65 price target, representing implied upside of 93% to current levels.
EU accuses Apple of violating Digital Market Act
Apple, meanwhile, made its own headlines today after the European Union said the tech giant is blocking developers from offering customers other options outside of its App Store. The charges are the first to be filed under the EU's Digital Market Act, which was passed earlier this year and aims to protect competition in the digital space.
While Apple said in a statement that it is "confident our plan complies with the law," a verdict against the company could result in a fine equivalent to 10% of its global revenue.
Related content
To continue reading this article
please register for free
This is different from signing in to your print subscription
Why am I seeing this? Find out more here
With over a decade of experience writing about the stock market, Karee Venema is the senior investing editor at Kiplinger.com. She joined the publication in April 2021 after 10 years of working as an investing writer and columnist at Schaeffer's Investment Research. In her previous role, Karee focused primarily on options trading, as well as technical, fundamental and sentiment analysis.
-
Stock Market Today: Stocks Struggle for Direction on Inflation Concerns
Another hot inflation reading from overseas and some real estate weakness at home made for a choppy session.
By Dan Burrows Published
-
Southwest Airlines Cuts Q2 Revenue Outlook Amid Higher Costs
Southwest Airlines stock is choppy Wednesday after the company cut its revenue guidance for the second quarter. Here's what you need to know.
By Joey Solitro Published
-
Stock Market Today: Stocks Struggle for Direction on Inflation Concerns
Another hot inflation reading from overseas and some real estate weakness at home made for a choppy session.
By Dan Burrows Published
-
Southwest Airlines Cuts Q2 Revenue Outlook Amid Higher Costs
Southwest Airlines stock is choppy Wednesday after the company cut its revenue guidance for the second quarter. Here's what you need to know.
By Joey Solitro Published
-
Rivian Stock is Red-Hot on $5 Billion Volkswagen Team Up
Rivian stock is surging after news broke that Volkswagen Group will invest a total of $5 billion into the EV maker. Here's what you need to know.
By Joey Solitro Published
-
FedEx Stock Soars on Big Earnings Beat: What To Know
FedEx stock is higher Wednesday after the logistics giant's impressive earnings results and upbeat outlook. Here's what you need to know.
By Joey Solitro Published
-
Stock Market Today: S&P 500, Nasdaq Snap Losing Streaks
Nvidia regained $197 billion in market value thanks to Tuesday's buy-the-dip session.
By Karee Venema Published
-
How This JPMorgan Factor Fund Keeps Up With the Broad Market
The JPMorgan U.S. Quality Factor ETF picks stocks based on profitability criteria and boasts a similar return as the S&P 500 but with less volatility.
By Nellie S. Huang Published
-
A Steady Fund for Bond Market Volatility
Uncertainty around interest rates has the bond market on pins and needles, but this top Fidelity fund can give investors peace of mind.
By Nellie S. Huang Published
-
The Future of Weight-Loss Drugs for Investors
Pharmaceuticals for shedding pounds can drive gains for investors.
By Adam Shell Published